Return to Listing

1 result(s) for DCDS4501A

PI Name Protocol # Title
Andy Chen IRB00010274 A Phase Ib Study Evaluating the Safety, Tolerability and Anti-Tumor Activity of DCDS4501A in Combination with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients with B-Cell Non-Hodgkin’s Lymphoma
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080

You may qualify for additional trials within our Phase 1 Program